We are live on ! Find out more
CJL

Cyrus J. Lawrence Portfolio holdings

AUM $26.4M
1-Year Est. Return 16.63%
This Fund
S&P 500
This Quarter Est. Return
+11.06%
1 Year Est. Return
+16.63%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$462K
AUM Growth
-$343M
Cap. Flow
-$8.24M
Cap. Flow %
-1,783.16%
Top 10 Hldgs %
53.52%
Holding
157
New
4
Increased
29
Reduced
27
Closed
9

Top Buys

Rank Stock Value
1
MDT icon
Medtronic
MDT
+$6.99M
2
AVGO icon
Broadcom
AVGO
+$6.76M
3
AMZN icon
Amazon
AMZN
+$3.3M
4
ZBH icon
Zimmer Biomet
ZBH
+$3.25M
5
SYK icon
Stryker
SYK
+$3.13M

Top Sells

Rank Stock Value
1
J icon
Jacobs Solutions
J
+$7.02M
2
PFE icon
Pfizer
PFE
+$6.43M
3
CVS icon
CVS Health
CVS
+$6.39M
4
QCOM icon
Qualcomm
QCOM
+$5.12M
5
SLB icon
SLB Ltd
SLB
+$3.08M

Sector Composition

Rank Sector Weight
1 Healthcare 35.4%
2 Technology 22.91%
3 Financials 9.51%
4 Consumer Discretionary 8.38%
5 Communication Services 5.61%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VZ icon
51
Verizon
VZ
$197B
$801 0.17%
2,197
+5
+0.2% +$185
BAC icon
52
Bank of America
BAC
$429B
$506 0.11%
17,670
-500
-3% -$14.3K
VOT icon
53
Vanguard Morningstar Mid-Cap Growth ETF
VOT
$18.9B
$431 0.09%
2,095
– –
CL icon
54
Colgate-Palmolive
CL
$74.8B
$408 0.09%
5,300
– –
ITW icon
55
Illinois Tool Works
ITW
$84.1B
$297 0.06%
1,188
– –
NJR icon
56
New Jersey Resources
NJR
$6B
$247 0.05%
5,250
– –
CCI icon
57
Crown Castle
CCI
$34.6B
$245 0.05%
2,157
-4,336
-67% -$516K
CSCO icon
58
Cisco
CSCO
$443B
$241 0.05%
4,663
– –
IBM icon
59
IBM
IBM
$213B
$227 0.05%
1,698
-31
-2% -$4K
ITCI
60
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$224 0.05%
3,550
– –
DIS icon
61
Walt Disney
DIS
$171B
$214 0.05%
2,400
– –
DT
62
DELISTED
DEUTSCHE TELEKOM AG ADS (1ORD)
DT
$210 0.05%
9,650
– –
FMC icon
63
FMC
FMC
$1.25B
$198 0.04%
1,900
– –
PG icon
64
Procter & Gamble
PG
$340B
$183 0.04%
1,212
– –
NVDA icon
65
NVIDIA
NVDA
$4.6T
$164 0.04%
3,880
-750
-16% -$24.9K
ABBV icon
66
AbbVie
ABBV
$465B
$159 0.03%
1,182
-10
-0.8% -$1.47K
LMT icon
67
Lockheed Martin
LMT
$131B
$158 0.03%
344
-45
-12% -$20.9K
IFF icon
68
International Flavors & Fragrances
IFF
$20.3B
$137 0.03%
1,725
– –
PFE icon
69
Pfizer
PFE
$143B
$135 0.03%
3,701
-165,128
-98% -$6.43M
BNY
70
Bank of New York Mellon
BNY
$103B
$134 0.03%
3,021
– –
BRK.B icon
71
Berkshire Hathaway Class B
BRK.B
$1.1T
$131 0.03%
3,849
– –
BMO icon
72
Bank of Montreal
BMO
$123B
$126 0.03%
1,400
– –
AXP icon
73
American Express
AXP
$224B
$123 0.03%
711
– –
QQQ icon
74
Invesco QQQ Trust
QQQ
$436B
$123 0.03%
333
+33
+11% +$11.1K
WM icon
75
Waste Management
WM
$95B
$111 0.02%
645
– –
1 2
3
4 5

Similar funds

FGN
Foundry Group Next Boulder, Colorado $21.1M AUM 35.51% 1-Year Est. Return
SFAM
Springhill Fund Asset Management Hong Kong $20.9M AUM
NTIMCH
New Thinking Investment Management Company (HK) Hong Kong $20.4M AUM 4.24% 1-Year Est. Return
GDCML
Galaxy Digital Capital Management LP New York $13.5M AUM
AA
AlphaQ Advisors Winter Park, Florida $41.7M AUM 12.96% 1-Year Est. Return
GIS
Grayhawk Investment Strategies Calgary, Alberta, Canada $43.9M AUM 6.23% 1-Year Est. Return
TC
Tarsadia Capital New York $5.64M AUM 15.7% 1-Year Est. Return
OWP
Old Well Partners Charlotte, North Carolina $4.55M AUM 27.75% 1-Year Est. Return

Cyrus J. Lawrence's Q2 2023 Portfolio in Review

As of Q2 2023, Cyrus J. Lawrence held 157 positions worth $462K, down 100% from $344M the previous quarter. Its ten largest holdings account for 54% of the portfolio.

Cyrus J. Lawrence withdrew a net $8.24M in Q2 2023, closing 9 positions and reducing 27 holdings. Its most notable exit was Merck, an estimated $3.03M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 35% of assets, up from 16% a quarter earlier, followed by Technology and Financials.

Against the trend, Cyrus J. Lawrence opened a new position in Broadcom worth $8.22K.

  • Cyrus J. Lawrence's largest Q2 2023 buy was Broadcom: 94,800 shares worth $8.22K.
  • Cyrus J. Lawrence added most to Medtronic in Q2 2023, an estimated $6.99M increase.
  • Cyrus J. Lawrence's biggest Q2 2023 reduction was Jacobs Solutions, cutting an estimated $7.02M.
  • Cyrus J. Lawrence fully exited Merck in Q2 2023, selling an estimated $3.03M.
  • Cyrus J. Lawrence's ten largest holdings make up 54% of its $462K portfolio in Q2 2023.
  • Cyrus J. Lawrence opened 4 new positions and closed 9 in Q2 2023.
  • Cyrus J. Lawrence's portfolio value fell 100% quarter-over-quarter to $462K.

Based on Cyrus J. Lawrence's 13F filing for Q2 2023, filed 11 Aug 2023.